<DOC>
	<DOC>NCT00976612</DOC>
	<brief_summary>In patients who are receiving nilotinib, nilotinib plasma levels will be measured after 1 month of nilotinib treatment. The relationship between surgery type and nilotinib pharmakokinetic properties will be investigated in this study.</brief_summary>
	<brief_title>Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST)</brief_title>
	<detailed_description />
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Patients with metastatic or unresectable gastrointestinal stromal tumor Patients receiving nilotinib after failure to imatinib and sunitinib</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Gastrointestinal stromal tumor</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>nilotinib</keyword>
</DOC>